Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WNT7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BLVRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF408 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HARBI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKBKG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YY1AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6791 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UXT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NADK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on